Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women

Breast Journal

Volumn 8, Issue 4, 2002, Pages 209-215

  Miyoshi, Yasuo ^a   Takahashi, Yuri ^a   Egawa, Chiyomi ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; CYP1A1; Estrogen; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1; ESTROGEN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CAUCASIAN; CODON; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DNA PRIMERS; FEMALE; HUMANS; JAPAN; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0036328868     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2002.08404.x     Document Type: Article

References (36)

1. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study
2. Breast cancer epidemiology: Summary and future directions
3. A polymorphism in the CYP17 gene increases the risk of breast cancer
4. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
5. CYP17 genotype and breast cancer risk
6. Association between CYP17 polymorphisms and the development of breast cancer
7. A rare CYP19 (aromatase) variant may increase the risk of breast cancer
8. Association between CYP17 gene polymorphism and risk of breast cancer in young women
9. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk
10. Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk
11. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
12. No association of the 5′ promoter region polymorphism of CYP17 with breast cancer risk in Japan
13. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women
14. Breast cancer risk associated with polymorphism in CYP19 in Japanese women
15. A systematic review of genetic polymorphisms and breast cancer risk
16. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans
17. 16 alpha-hydroxylation of estradiol: A possible risk marker for breast cancer
18. Urinary 2-hydroxyestrone/16 alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
19. CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women
20. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study
21. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans
22. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk
23. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan
24. The pathology of breast cancer in Japanese women compared to other ethnic groups: A review
25. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk
26. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas
27. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer
28. Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan
29. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose
30. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer
31. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes
32. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations
33. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility
34. CYP1N1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China
35. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk
36. Interindividual variation in CYP1N1 expression in breast tissue and the role of genetic polymorphism